Gelmetix

United Kingdom
Macclesfield, England, United Kingdom, SK10 4

Company profile

Gelmetix company profile

Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is a hydrogel for nucleus pulposus augmentation to relieve pain in patients suffering from Chronic Low Back Pain. Gelmetix is a diversified therapeutic biomaterials company incorporated in the UK. It has offices in London, Paris, and Manchester.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2012-01-01, Year

Headquarters

Postal code
SK10 4
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$14.7M
Last funding
Series C / $7.1M / 2021-05-14
Last equity funding
Series C / $7.1M
Investors
6
Lead investors
3
Founders
3
Articles
2

Founders and investors

Founders

Brian R SaundersPhilippe JennyTony Freemont

Lead investors

Jonathan MilnerSeneca PartnersThe North West Fund

Investors

Fund Twenty8Jonathan MilnerSeneca PartnersUniversity of ManchesterWealth Club